Trials / Completed
CompletedNCT02142894
Evaluation of the QuantiFERON-TB Test.
Evaluation of the 4th Generation QuantiFERON-TB Test (CST001) for the Detection of Tuberculosis Infection
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 33 (actual)
- Sponsor
- QIAGEN Gaithersburg, Inc · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
To compare the results of the investigational test to the currently approved QuantiFERON-TB Gold In-Tube test.
Detailed description
The objective of the study was to enroll patients who have clinical signs/symptoms strongly indicating TB and who are receiving of have to start the treatment for active TB, and test the variants of the CST001 assay to support the evaluation of clinical sensitivity.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CST001 |
Timeline
- Start date
- 2014-05-27
- Primary completion
- 2016-03-28
- Completion
- 2016-03-28
- First posted
- 2014-05-20
- Last updated
- 2019-06-18
- Results posted
- 2019-06-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02142894. Inclusion in this directory is not an endorsement.